UK - CellCentric receives £1.15m DTI award
CellCentric, a venture-backed epigenetics company, has been awarded ТЃ1.15m from the Department of Trade and Industryтs (DTI) technology programme, as part of a ТЃ2.3m collaborative programme with three leading research institutions.
CellCentric was founded in May 2004 with initial funding from Avlar BioVentures and Providence Investment Trust and subsequently from The Rainbow Seed Fund and the National Endowment for Science Technology and the Arts (NESTA).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








